Skip to nav Skip to content
Facebook Twitter LinkedIn Email

IDSA HIVMA Joint Logo Updated.png



IDSA and HIVMA Support BIO Preparedness Workforce Act 

Bipartisan Bill Helps Build Infectious Diseases Workforce Needed to Combat Public Health Threats & Expand Care Access 

The Infectious Diseases Society of America and HIV Medicine Association applaud the bipartisan introduction of the Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act by Reps. Lori Trahan (D-MA) and David McKinley (R-WV), H.R. 5602, and its inclusion in an Oct. 26 Energy and Commerce Health Subcommittee hearing. The bill would help ensure a sufficient, diverse bio-preparedness and infectious diseases workforce to meet current and future public health threats. 

The BIO Preparedness Workforce Act would establish new loan repayment opportunities for health care professionals who spend at least 50% of their time working in bio-preparedness in a health care facility anywhere in the U.S. or who spend at least 50% of their time providing infectious diseases care in underserved areas or federally funded facilities. The bill permits the Secretary of HHS to award loan repayment contracts under this bill in a manner that increases the number of ID and bio-preparedness health care professionals from populations underrepresented in medicine. 

“Even before the COVID-19 pandemic, the infectious diseases workforce was under serious strain. A June 2020 study in the Annals of Internal Medicine found that 208 million Americans live in areas with little or no access to an infectious diseases physician. Despite strong interest in the field among medical students, year after year infectious diseases fellowship training programs are unable to fill all their slots, as high student debt drives many physicians toward more lucrative specialties. The opportunity for loan repayment will help make ID a financially feasible career choice and help ensure infectious diseases expertise is available where it is most needed,” explained Dan McQuillen, MD, FIDSA, president of IDSA. 

Throughout the COVID-19 pandemic, shortages of infectious diseases clinicians, laboratory professionals, infection preventionists and other experts have hampered the nation’s ability to respond. Limited access to experienced infectious diseases and HIV health care professionals in many communities also has challenged the health care system’s ability to respond to other serious public health issues and epidemics including antimicrobial resistance, HIV, viral hepatitis and infections associated with drug use. 

“A strong, diverse infectious diseases workforce in communities across the United States is critical to advance health equity, promote our resilience for future pandemics and end persistent epidemics like HIV,” stated Marwan Haddad, MD, MPH, HIVMA chair. “Building a sufficient and expert infectious diseases workforce must go hand in hand with developing effective tools for preventing and treating COVID-19, HIV and other infectious diseases to ensure they can be successfully deployed and reach vulnerable and underserved communities and populations.”  

It is essential that the federal government apply lessons learned from the COVID-19 pandemic to strengthen our country’s response to infectious diseases and our preparedness for future health threats. Securing and diversifying the infectious diseases workforce are critical first steps.  

IDSA and HIVMA urge Congress to act swiftly to advance the bipartisan BIO Preparedness Workforce Act.  


This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.